US Patent 10196445 Ipilimumab variant with enhanced ADCC
Patent 10196445 was granted and assigned to Bristol-Myers Squibb on February, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 16, 2016
Date of Patent
February 5, 2019
Patent Applicant
Patent Application Number
15071489
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10196445 Ipilimumab variant with enhanced ADCC
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
